Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia
A phase 3 trial of Amsacrine, Asparaginase, Cytarabine, Daunorubicin, Etoposide, Methotrexate and Mitoxantrone in Leukaemia and Myelodysplastic syndromes / neoplasms, run by Medical Research Council, completed.
Overview
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia is a phase 3 interventional study registered as NCT00003436 by Medical Research Council, with 2000 participants recorded, started 1998-07. Interventions recorded: amsacrine, asparaginase, cytarabine, daunorubicin hydrochloride, etoposide, methotrexate, mitoxantrone hydrochloride, therapeutic hydrocortisone, allogeneic bone marrow transplantation. Conditions recorded: Leukemia, Myelodysplastic Syndromes.
Linked to the drug Amsacrine because the registry names it among its interventions and Leukaemia and Myelodysplastic syndromes / neoplasms among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialResponse-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
Shares Mitoxantrone, Asparaginase (pegaspargase, calaspargase pegol, Erwinia asparaginase), Daunorubicin, Cytarabine and the tag pipeline.
- TrialCombination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia
Shares Amsacrine, Mitoxantrone, Daunorubicin, Cytarabine and the tag pipeline.
- TrialCombination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia
Shares Amsacrine, Mitoxantrone, Cytarabine, Leukaemia (all types) and the tag pipeline.
- TrialTreatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia
Shares Mitoxantrone, Daunorubicin, Cytarabine, Leukaemia (all types) and the tag pipeline.
- TrialCombination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Shares Asparaginase (pegaspargase, calaspargase pegol, Erwinia asparaginase), Daunorubicin, Cytarabine, Leukaemia (all types) and the tag pipeline.
- TrialA Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Shares Mitoxantrone, Asparaginase (pegaspargase, calaspargase pegol, Erwinia asparaginase), Daunorubicin, Cytarabine and the tag pipeline.
- TrialCombination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
Shares Asparaginase (pegaspargase, calaspargase pegol, Erwinia asparaginase), Daunorubicin, Cytarabine, Leukaemia (all types) and the tag pipeline.
- TrialA Safety and Efficacy Study of Eltrombopag in Subjects With AML
Shares Daunorubicin, Cytarabine, Leukaemia (all types) and the tag pipeline.